Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• Posttraumatic stress disorder (PTSD) is characterized by an inability to suppress fear responses in safe contexts.
• Hypersensitivity of the hypothalamic-pituitary-adrenal (HPA) axis feedback is a common finding in PTSD.
• Shared neurobiological pathways suggest a link between HPA axis function and fear inhibition deficits in PTSD.

Purpose of the Study:

• To investigate the relationship between HPA axis function and fear inhibition in trauma-exposed individuals.
• To examine fear-potentiated startle and conditioned fear inhibition using a conditional discrimination paradigm.
• To assess neuroendocrine responses, including cortisol and ACTH levels, following the dexamethasone suppression test (DEX).

Main Methods:

• A conditional discrimination procedure (AX+/BX-) was employed, pairing shapes with aversive airblasts (AX+) or safety signals (BX-).
• Fear-potentiated startle and a fear inhibition test (AB) were measured.
• Blood samples were collected for neuroendocrine analysis (cortisol, ACTH) before and after DEX administration in 90 trauma-exposed individuals (29 with PTSD, 61 controls).

Main Results:

• Subjects with PTSD showed significantly higher fear-potentiated startle to safety signals (BX-) and fear inhibition trials (AB) compared to controls.
• Fear-potentiated startle in PTSD subjects was positively correlated with baseline and post-DEX ACTH levels.
• Both PTSD and control groups demonstrated significant reductions in cortisol and ACTH post-DEX.

Conclusions:

• Impaired fear inhibition in PTSD is associated with altered HPA axis feedback.
• These findings suggest that amygdala hyperactivity may underlie both fear inhibition deficits and HPA axis dysregulation in PTSD.
• The study highlights potential neurobiological mechanisms contributing to PTSD symptoms.